BridgeMD
New treatment option for Periodontitis Stage II
Official title 3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV
ClinicalTrials.gov ID: NCT07293962
What this study is testing
What is Platelet rich fibrin?
Platelet rich fibrin is an investigational medicine, given as a monthly pill taken by mouth, being studied as a potential treatment for periodontitis stage ii.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- What is the purpose of this study? This study is to investigate the effect of a processed blood product in healing after treatment for gum disease.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Have at least 20 teeth,
- American Society of Anesthesiology class I or II
- Periodontitis stages II-IV
- Bilateral sites of deep periodontal pockets ≥5 mm
You likely can't join if
- Limited mouth opening or symptomatic temporomandibular joint disorder
- Inability to tolerate extended long periodontal treatment and/or hyperactive gag reflex
- Current or former smoker or vape user
- Pregnant and/or breastfeeding
- Having diabetes mellitus type I or II
- Having bleeding disorder or is on anticoagulants
See the full eligibility criteria
- Have at least 20 teeth,
- American Society of Anesthesiology class I or II
- Periodontitis stages II-IV
- Bilateral sites of deep periodontal pockets ≥5 mm
- Limited mouth opening or symptomatic temporomandibular joint disorder
- Inability to tolerate extended long periodontal treatment and/or hyperactive gag reflex
- Current or former smoker or vape user
- Pregnant and/or breastfeeding
- Having diabetes mellitus type I or II
- Having bleeding disorder or is on anticoagulants
- Underwent periodontal treatment and/or surgery in past 6 months prior
- Undergoing orthodontic therapy, or completed in past 3 months prior
- On or had anti-inflammatory drug(s) in past 3 months prior
- On or had antibiotic(s) in past 3 months prior
- Having autoimmune disorder
- On or had immunosuppressant drug(s) in past 3 months prior
- Undergoing or underwent radio- and/or chemo-therapy
The study team makes the final eligibility decision.
Where it's taking place
- Jenjarum, Selangor, Malaysia
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jenjarum, Selangor, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.